AccuBio Ltd launched VISITECT CD4 Advanced Disease to address the critical need to identify AHD and accelerate clinical decision making, providing a low cost, true in-field POC solution for community CD4 testing.

Public source

Publisher name

Public post

An interesting article highlighting the current CD4 testing landscape and the challenges faced. The decline in conventional CD4 testing, coupled with the observed reduct…

Log in to read the full post

Company

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.